Bharat Biotech International and the University of Sydney Infectious Diseases Institute (Sydney ID) entered into a Memorandum of Understanding (MoU) to advance vaccine research initiatives.It...
Continue ReadingAurobindo Pharma on November 30 said its subsidiary has received approval from the U.S. health regulator to market a generic medication to treat asthma in...
Continue ReadingDr. Reddy’s Laboratories launched Nerivio, a state-of-the-art United States Food and Drug Administration (USFDA) approved wearable therapy device for drug-free management of migraine, in the...
Continue ReadingResearchers at the National Institutes of Health have developed a way to potentially increase the effectiveness of T cell–based immunotherapy treatments, such as CAR T-cell...
Continue ReadingAccording to a report in the media, Mankind Pharma and Baidyanath Ayurveda, along with other entities including a private equity fund and an asset reconstruction...
Continue ReadingIt has entered into a licensing agreement with Zydus Lifesciences to co-market the latter’s drug desidustat in India, used in treatment for anemia associated with...
Continue ReadingSvaas Wellness, the healthtech arm of pharma major Dr. Reddy’s, (October 25) announced the launch of its ecommerce platform, Celevida Wellness, for diabetes patients.The new...
Continue ReadingAragen is setting up a new biologics manufacturing facility in Bangalore, India. The facility is part of a $30 million investment, spanning nearly 160,000 sq...
Continue ReadingZydus Lifesciences said it has inked a pact with Sun Pharma to sell in the country an oral treatment medication for anemia associated with chronic...
Continue Reading